Pediatric RSV Vaccine Safety Casts A ‘Long Shadow’ For US FDA

 
• By Michael McCaughan
  
The VRBPAC's message that safeguards were effective in pediatric vaccine trials may not be the last word on the subject. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pathways & Standards